1 Min Read
Nov 15 (Reuters) -
* Naia Rare Diseases announces clinical trial authorisation (CTA) to initiate clinical trials of NB 1001 for short bowel syndrome in the United Kingdom Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.